| 1. |
胡建昆,陳心足.進展期胃癌治療方式合理選擇及評價[J].中國實用外科雜志,2011,31(8):720-722.
|
| 2. |
胡建昆,陳心足.胃癌多學科協作診療模式現狀[J].中國普外基礎與臨床雜志,2012,19(1):1-3.
|
| 3. |
Hu B,El Hajj N,Sittler S,et al.Gastric cancer:Classification,histology and application of molecular pathology[J].J Gastrointest Oncol,2012,3(3):251-261.
|
| 4. |
何裕隆.胃癌病理分型研究進展[J].中國實用外科雜志,2005,25(7):438-440.
|
| 5. |
Santiago JM,Sasako M,Osorio J.TNM-7th edition 2009(UICC/AJCC) and Japanese Classification 2010 in Gastric Cancer.Tow-ards simplicity and standardisation in the management of gastric cancer[J].Cir Esp,2011,89(5):275-281.
|
| 6. |
Japanese Gastric Cancer Association.Japanese gastric cancer treatment guidelines 2010(ver.3)[J].Gastric Cancer,2011,14(2):113-123.
|
| 7. |
Liang YX,Guo HH,Deng JY,et al.Impact of intraoperative blood loss on survival after curative resection for gastric cancer[J].World J Gastroenterol,2013,19(33):5542-5550.
|
| 8. |
Yang B,Wu G,Wang X,et al.Discussion of modifying stage Ⅳ gastric cancer based on Borrmann classification[J].Tumour Biol,2013,34(3):1485-1491.
|
| 9. |
Sun XC,Lin J,Ju AH.Treatment of Borrmann type Ⅳ gastric cancer with a neoadjuvant chemotherapy combination of docetaxel,cisplatin and 5-fluorouracil/leucovorin[J].J Int Med Res,2011,39(6):2096-2102.
|
| 10. |
Siewert JR,Stein HJ.Classification of adenocarcinoma of the oesophagogastric junction[J].Br J Surg,1998,85(11):1457-1459.
|
| 11. |
Sasako M,Sano T,Yamamoto S,et al.Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia:a randomised controlled trial[J].Lancet Oncol,2006,7(8):644-651.
|
| 12. |
Mine S,Sano T,Hiki N,et al.Proximal margin length with trans-hiatal gastrectomy for Siewert type Ⅱ and Ⅲ adenocarcinomas of the oesophagogastric junction[J].Br J Surg,2013,100(8):1050-1054.
|
| 13. |
Lauren P.The two histological main types of gastric carcinoma:Diffuse and so-called intestinal-type carcinoma.An attempt at a histo-clinical classification[J].Acta Pathol Microbiol Scand,1965,64:31-49.
|
| 14. |
Lauwers GY,Carneiro F,Graham DY.Gastric carcinoma[A]//Bowman FT,Carneiro F,Hruban RH,eds.Classification of tumours of the digestive system[M].Lyon:IARC,2010.In press.
|
| 15. |
李忠武,曹登峰.胃癌病理分型與臨床個體化治療——問題與展望[J].中國醫學前沿雜志:電子版,2012,4(5):15-20.
|
| 16. |
Liu L,Wang ZW,Ji J,et al.A cohort study and meta-analysis between histopathological classification and prognosis of gastric carcinoma[J].Anticancer Agents Med Chem,2013,13(2):227-234.
|
| 17. |
Qiu MZ,Cai MY,Zhang DS,et al.Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China[J].J Transl Med,2013,11:58.
|
| 18. |
Lorenzen S,Blank S,Lordick F,et al.Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients[J].Ann Surg Oncol,2012,19(7):2119-2127.
|
| 19. |
Becker K,Langer R,Reim D,et al.Significance of histopatho-logical tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas:a summary of 480 cases[J].Ann Surg,2011,253(5):934-939.
|
| 20. |
Kucukoner M,Isikdogan A,Arpaci E,et al.Adjuvant chemora-diation for gastric cancer:multicentric study of the Anatolian Soc-iety of Medical Oncology[J].Hepatogastroenterology,2012,59(119):2343-2347.
|
| 21. |
Kucukoner M,Arpaci E,Isikdogan A,et al.Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy[J].Neoplasma,2013,60(1):19-25.
|
| 22. |
Yonemura Y,Ninomiya I,Yamaguchi A,et al.Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer[J].Cancer Res,1991,51(3):1034-1038.
|
| 23. |
Kataoka Y,Okabe H,Yoshizawa A,et al.HER2 expression and its clinicopathological features in resectable gastric cancer[J].Gastric Cancer,2013,16(1):84-93.
|
| 24. |
Aizawa M,Nagatsuma AK,Kitada K,et al.Evaluation of HER2-based biology in 1006 cases of gastric cancer in a Japanese population[J].Gastric Cancer,2013 Feb 22.[Epub ahead of print].
|
| 25. |
Zhou F,Li N,Jiang W,et al.Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curati-vely resected gastric cancer after the ToGA clinical trial[J].World J Surg Oncol,2012,10:274.
|
| 26. |
Jorgensen JT.Targeted HER2 treatment in advanced gastric cancer[J].Oncology,2010,78(1):26-33.
|
| 27. |
Bang YJ,Van Cutsem E,Feyereislova A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA):a phase 3,open-label,randomised controlled trial[J].Lancet,2010,376(9742):687-697.
|
| 28. |
Tanner M,Hollmen M,Junttila TT,et al.Amplification of HER-2 in gastric carcinoma:association with Topoisomerase Ⅱalpha gene amplification,intestinal type,poor prognosis and sensitivity to trastuzumab[J].Ann Oncol,2005,16(2):273-278.
|
| 29. |
Fan XS,Chen JY,Li CF,et al.Differences in HER2 over-exp-ression between proximal and distal gastric cancers in the Chinese population[J].World J Gastroenterol,2013,19(21):3316-3323.
|
| 30. |
Marx AH,Tharun L,Muth J,et al.HER-2 amplification is highly homogenous in gastric cancer[J].Hum Pathol,2009,40(6):769-777.
|
| 31. |
Jorgensen JT,Hersom M.HER2 as a prognostic marker in gastric cancer:a systematic analysis of data from the literature[J].J Cancer,2012,3:137-144.
|
| 32. |
Okines AF,Cunningham D.Trastuzumab in gastric cancer[J].Eur J Cancer,2010,46(11):1949-1959.
|
| 33. |
Okines AF,Cunningham D.Trastuzumab:a novel standard opt-ion for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer[J].Therap Adv Gastroenterol,2012,5(5):301-318.
|
| 34. |
Rüschoff J,Hanna W,Bilous M,et al.HER2 testing in gastric cancer:a practical approach[J].Mod Pathol,2012,25(5):637-650.
|
| 35. |
Sun Z,Wang ZN,Zhu Z,et al.Evaluation of the seventh edit-ion of American Joint Committee on Cancer TNM staging system for gastric cancer:results from a Chinese monoinstitutional study[J].Ann Surg Oncol,2012,19(6):1918-1927.
|
| 36. |
Reim D,Loos M,Vogl F,et al.Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer:the Western experience of patients treated in a single-center European institution[J].J Clin Oncol,2013,31(2):263-271.
|
| 37. |
Yoon HM,Ryu KW,Nam BH,et al.Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer?[J].J Am Coll Surg,2012,214(1):88-96.
|
| 38. |
Strong VE,D'Amico TA,Kleinberg L,et al.Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers[J].J Natl Compr Canc Netw,2013,11(1):60-66.
|
| 39. |
Isomoto H,Shikuwa S,Yamaguchi N,et al.Endoscopic submu-cosal dissection for early gastric cancer:a large-scale feasibility study[J].Gut,2009,58(3):331-336.
|
| 40. |
Chen XZ,Hu JK,Yang K,et al.Short-term evaluation of lapar-oscopy-assisted distal gastrectomy for predictive early gastric cancer:a meta-analysis of randomized controlled trials[J].Surg Laparosc Endosc Percutan Tech,2009,19(4):277-284.
|
| 41. |
Chen XZ,Li YY,Hu JK,et al.Spread and development of laparoscopic surgery for gastric tumors in mainland China:initial experiences[J].Hepatogastroenterology,2012,59(114):654-658.
|
| 42. |
Wen L,Chen XZ,Wu B,et al.Total vs. proximal gastrectomy for proximal gastric cancer:a systematic review and meta-analysis[J].Hepatogastroenterology,2012,59(114):633-640.
|
| 43. |
Chen XZ,Yang K,Liu J,et al.Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer[J].World J Gastroenterol,2011,17(40):4542-4544.
|
| 44. |
胡建昆,陳心足.食管胃結合部腺癌圍手術期放化療合理應用及評價[J].中國實用外科雜志,2012,32(4):303-306.
|
| 45. |
Schuhmacher C,Gretschel S,Lordick F,et al.Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia:European Organisation for Research and Treatment of Cancer randomized trial 40954[J].J Clin Oncol,2010,28(35):5210-5218.
|
| 46. |
Hu JK,Li CM,Chen XZ,et al.The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma:A systematic review of published randomi-zed controlled trials[J].J Chemother,2007,19(4):359-375.
|
| 47. |
Paoletti X,Oba K,Burzykowski T,et al.Benefit of adjuvant chemotherapy for resectable gastric cancer:a meta-analysis[J].JAMA,2010,303(17):1729-1737.
|
| 48. |
National Comprehensive Cancer Network.Gastric Cancer (Inclu-ding cancer in the proximal 5 cm of the stomach) Version 2.2013.NCCN Clinical Practice Guilelines in Oncology 2013[EB/OL].http://www.nccn.org.
|
| 49. |
Fiori E,Lamazza A,Demasi E,et al.Endoscopic stenting for gastric outlet obstruction in patients with unresectable antro pylo-ric cancer.Systematic review of the literature and final results of a prospective study.The point of view of a surgical group[J].Am J Surg,2013,206(2):210-217.
|
